Vasa vasorum and plaque progression, and responses to atorvastatin in a rabbit model of atherosclerosis: Contrast-enhanced ultrasound imaging and intravascular ultrasound study

Heart

Volumn 99, Issue 1, 2013, Pages 48-54

  Tian, Jinwei ^a   Hu, Sining ^a   Sun, Yanli ^a   Yu, Huai ^a   Han, Xue ^a   Cheng, Wen ^a   Ban, Xiang ^a   Zhang, Shaosong ^b   Yu, Bo ^a   Jang, Ik Kyung ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b LightLab Imaging/St Jude Medical Westford   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CD31 ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SONOVUE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRAVASCULAR ULTRASOUND; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL; VASA VASORUM;

ANIMALS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CELL PROLIFERATION; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMAGE ENHANCEMENT; MALE; PLAQUE, ATHEROSCLEROTIC; PYRROLES; RABBITS; ULTRASONOGRAPHY, INTERVENTIONAL; VASA VASORUM;

EID: 84871277637     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302775     Document Type: Article

References (29)

1. Tian J, Hou J, Xing L, et al. Signi ficance of intraplaque neovascularisation for vulnerability: optical coherence tomography study. Heart 2012;98:1504-9.
2. Chung NA, Lydakis C, Belgore F, et al. Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Heart 2003;89:1411-15. (Pubitemid 37465236)
3. Chen J, Liu B, Yuan J, et al. Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production. Mol Oncol 2012;6:62-72.
4. Giannoni MF, Vicenzini E, Citone M, et al. Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study. Eur J Vasc Endovasc Surg 2009;37:722-7.
5. Moguillansky D, Leng X, Carson A, et al. Quantification of plaque neovascularization using contrast ultrasound: a histologic validation. Eur Heart J 2011;32:646-53.
6. Sipahi I, Tuzcu EM, Moon KW, et al. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? a serial intravascular ultrasound study. Heart 2008;94:623-7. (Pubitemid 351580138)
7. Meng L, Lv B, Zhang S, et al. In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model. Heart 2008;94:777-80. (Pubitemid 351744700)
8. Parolini C, Marchesi M, Lorenzon P, et al. Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging. J Am Coll Cardiol 2008;51:1098-103. (Pubitemid 351374769)
9. Iwata A, Miura S, Imaizumi S, et al . Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound. J Cardiol 2007;50:229-34. (Pubitemid 351699942)
10. Li TT, Xie Y, Guo Y, et al. Effect of probucol on vascular remodeling due to atherosclerosis in rabbits: an intravascular ultrasound study. Chin Med J (Engl) 2011;124:1840-7.
11. Skyba DM, Jayaweera AR, Goodman NC, et al. Quanti fication of myocardial perfusion with myocardial contrast echocardiography during left atrial injection of contrast. Implications for venous injection. Circulation 1994;90:1513-21. (Pubitemid 24284472)
12. Staub D, Schinkel AFL, Coll B, et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010;3:761-71.
13. Giannarelli C, Ibanez B, Cimmino G, et al. Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis. JACC Cardiovasc Imaging 2010;3:1256-64.
14. White SK, Sado DM, Flett AS, et al. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart 2012;98:773-9.
15. Jain RK, Finn AV, Kolodgie FD, et al. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Nat Clin Pract Cardiovasc Med 2007;4:491-502. (Pubitemid 47316647)
16. Moulton KS, Vakili K, Zurakowski D, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 2003;100:4736-41. (Pubitemid 36457799)
17. Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999;99:1726-32. (Pubitemid 29162486)
18. Langheinrich AC, Sedding DG, Kampschulte M, et al. 3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE(-/-)/LDL(-/-) double knockout mice. Atherosclerosis 2009;202:103-10.
19. Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation 2000;101:207-13. (Pubitemid 30044262)
20. Santana O, Mihos . Pleiotropic effects of the HMG-CoA reductase inhibitors. Int J Gen Med 2011;4:261-71.
21. Brili S, Tousoulis D, Antonopoulos AS, et al. Effects of atorvastatin on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young subjects with successfully repaired coarctation of aorta. Heart 2012;98:325-9.
22. Williams JK, Sukhova GK, Herrington DM, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol 1998;31:684-91. (Pubitemid 28144138)
23. Wilson SH, Herrmann J, Lerman LO, et al. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 2002;105:415-18. (Pubitemid 34141695)
24. Skaletz-Rorowski A, Kureishi Y, Shiojima I, et al. The pro- and antiangiogenic effects of statins. Semin Vasc Med 2004;4:395-400. (Pubitemid 40577828)
25. Zhu XY, Daghini E, Chade AR, et al. Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. Life Sci 2008;83:801-9.
26. Khaidakov M, Wang W, Khan JA, et al. Statins and angiogenesis: is it about connections? Biochem Biophys Res Commun 2009;387:543-7.
27. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659-61. (Pubitemid 351348146)
28. Bustos C, Hernandez-Presa MA, Ortego M, et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 1998;32:2057-64. (Pubitemid 29010476)
29. Yanni AE. The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim 2004;38:246-56. (Pubitemid 38962073)